Basel Medical Group Stock Analysis

Basel Stock Analysis Notes

About 54.0% of the company shares are held by company insiders. The book value of Basel Medical was currently reported as 0.21. The company recorded a loss per share of 0.51. Basel Medical Group had not issued any dividends in recent years. For more info on Basel Medical Group please contact the company at 65 6291 9188 or go to https://baselmedical.com.

Basel Medical Group Investment Alerts

Basel Medical Thematic Classifications

Basel Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 11.46 M.

Basel Profitablity

The company has Profit Margin (PM) of (1.0) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.09) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.09.

Management Efficiency

Basel Medical Group has return on total asset (ROA) of (0.0467) % which means that it has lost $0.0467 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.9456) %, meaning that it created substantial loss on money invested by shareholders. Basel Medical's management efficiency ratios could be used to measure how well Basel Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is expected to rise to -0.78 this year. Return On Capital Employed is expected to rise to -0.39 this year. At this time, Basel Medical's Non Current Assets Total are quite stable compared to the past year. Other Current Assets is expected to rise to about 8.8 M this year, although the value of Return On Tangible Assets are projected to rise to (0.78).

Technical Drivers

As of the 14th of February 2026, Basel Medical shows the Mean Deviation of 5.31, standard deviation of 7.73, and Risk Adjusted Performance of (0.09). Basel Medical Group technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Basel Medical Group information ratio and potential upside to decide if Basel Medical Group is priced correctly, providing market reflects its regular price of 0.63 per share. As Basel Medical Group is a penny stock we also strongly suggest to validate its jensen alpha numbers.

Basel Medical Group Price Movement Analysis

Basel Medical Outstanding Bonds

Basel Medical Predictive Daily Indicators

Basel Medical Forecast Models

Basel Medical's time-series forecasting models are one of many Basel Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Basel Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Basel Medical Bond Ratings

Basel Medical Group financial ratings play a critical role in determining how much Basel Medical have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Basel Medical's borrowing costs.

Basel Medical Total Assets Over Time

Basel Medical Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Basel Medical uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Basel Medical Debt Ratio

42.0

It seems about 58% of Basel Medical's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Basel Medical's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Basel Medical, which in turn will lower the firm's financial flexibility.

Basel Medical Corporate Bonds Issued

Basel Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Basel Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Basel shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Basel Medical. By using and applying Basel Stock analysis, traders can create a robust methodology for identifying Basel entry and exit points for their positions.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Basel Medical Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Investors evaluate Basel Medical Group using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Basel Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Basel Medical's market price to deviate significantly from intrinsic value.

It's important to distinguish between Basel Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Basel Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Basel Medical's market price signifies the transaction level at which participants voluntarily complete trades.